Paydirt
Insider filing · DRUG

Cormorant Asset Management, LP sold $9.8M of Bright Minds Biosciences (DRUG)

Executed Apr 28, disclosed Apr 30, 2 days later.

Value, as filed
$9.8M
109,331 sh × $89.50
Executed
Apr 28
the trade date, as filed
Disclosed
Apr 30
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
purchases only

Returns are measured on stock purchases only.

The filer
CL Cormorant Asset Management, LP Other profile →

Cormorant Asset Management, LP (Other) filed 2 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 2 sales), most often in DRUG. The largest single filing was $9.8M of DRUG (109,331 sh × $89.50, as filed), executed Apr 28.

The name
DRUG DRUG DRUG · 3 filings in 24 months ticker → Insider filings, newest first View the original filing at www.sec.gov
Other filings by Cormorant Asset Management, LP in DRUG
DRUGPURCHASE BRIGHT MINDS BIOSCIENCES INC. $4.0M
184,331 sh × $21.70
Exec Nov 4 2024
Filed Nov 6 2024 · 5:30 PM ET